Doctor profile · Federal record
Dr. Hesum Chegini, D.O
Rheumatology Physician (CMS: Rheumatology) · Sterling, VA
- NPI 1902197791
- Accepts Medicare
- MIPS 75.1 / 100 · 2023
- 15 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
21351 Gentry Dr Ste 125
Sterling, VA 201668511
(571) 545-4343
fax (571) 545-4342
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- April 4, 2025
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Virginia #0102204477
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902197791. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,926
Distinct HCPCS
9
Medicare allowed
$143,654
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,600 | 12 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 1,741 | 26 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 303 | 129 | $132 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 94 | 44 | $79 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 53 | 53 | $176 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | 13 | $1 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 35 | 19 | $138 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 32 | 28 | $92 | |
20610 |
Aspiration and/or injection of fluid from large joint | 19 | 14 | $69 |
In context: peer comparison
Among 1 peers in Sterling Rheumatology Physician, average services per provider: 1,102. This provider delivers 9.0× the peer median.Open Payments
Industry payments received
All-time total
$2,293
Transactions
103
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 22 | $455.10 | |
| Abbvie INC. | 24 | $417.72 | |
| Ucb, INC. | 15 | $254.90 | |
| Novartis Pharmaceuticals Corporation | 8 | $204.59 | |
| Janssen Biotech, INC. | 5 | $133.14 | |
| Lilly USA, LLC | 5 | $96.66 | |
| Pfizer INC. | 4 | $93.34 | |
| Mallinckrodt Hospital Products INC. | 3 | $88.59 | |
| Aurinia Pharma U.S., INC. | 3 | $76.59 | |
| Kiniksa Pharmaceuticals International, Plc | 3 | $73.58 | |
| GlaxoSmithKline, LLC. | 3 | $64.04 | |
| Sandoz INC. | 2 | $61.08 | |
| Genzyme Corporation | 2 | $48.29 | |
| Organon LLC | 2 | $44.37 | |
| Alexion Pharmaceuticals, INC. | 2 | $41.56 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
217
Patients
85
Total drug cost
$334,901
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 54 | 28 | $353 |
| Methotrexate (Methotrexate Sodium) | Brand | 48 | 25 | $2,853 |
| Hydroxychloroquine Sulfate | Generic | 31 | 20 | $2,271 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 22 | 0 | $160,913 |
| Leflunomide | Generic | 21 | 12 | $1,885 |
| Humira(Cf) Pen (Adalimumab) | Brand | 17 | 0 | $160,197 |
| Allopurinol | Generic | 12 | 0 | $89 |
| Rasuvo (Methotrexate/Pf) | Brand | 12 | 0 | $6,341 |
Frequently asked questions
What is Dr. Hesum Chegini's medical specialty?
Dr. Hesum Chegini practices Rheumatology Physician in Sterling, VA.
Where does Dr. Hesum Chegini practice?
Dr. Hesum Chegini practices at 21351 Gentry Dr Ste 125, Sterling, VA 201668511. Office phone: 5715454343.
What is Dr. Hesum Chegini's NPI?
Dr. Hesum Chegini's National Provider Identifier (NPI) is 1902197791, issued by NPPES.
Does Dr. Hesum Chegini accept Medicare assignment?
Yes. Dr. Hesum Chegini accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Hesum Chegini commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.